Live Breaking News & Updates on Zhuang Shilihe

Stay updated with breaking news from Zhuang shilihe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chinese mass inoculation plan not hindered by vaccine shortage, fluctuating supply is regional, temporary


CHINA / SOCIETY
By GT staff reporters Published: Apr 09, 2021 10:38 PM
People line up to get vaccinated in front of a mobile vaccination vehicle in Beijing on Friday. Setting up COVID-19 vaccination sites in areas with heavy traffic will help improve the efficiency of vaccination and also spread vaccination information. Photo: cnsphoto
Through measures like prolonging injection intervals and prioritizing high-risk areas and groups, China is making efforts to maintain a balance in COVID-19 vaccine supply and demand while some places in China are reportedly facing a temporary COVID-19 vaccine shortage during the country s accelerating vaccination drive, which is aimed at guaranteeing the reported goal of the country to vaccinate about 560 million people by the end of June, Chinese experts said.    ....

Tao Lina , Zhuang Shilihe , Feng Duojia , Authority Of South China Guangdong Province , Sinovac Biotech , Information Technology , National Health Commission , Ministry Of Industry , China Vaccine Industry Association , South China , Hainan Province , Guangdong Province , Northwest China , Shaanxi Province , Global Times , Hong Kong Special Administrative Region , Central China , Hunan Province , Northeast China , தாவோ லினா , தகவல் தொழில்நுட்பம் , தேசிய ஆரோக்கியம் தரகு , அமைச்சகம் ஆஃப் தொழில் , சீனா தடுப்பூசி தொழில் சங்கம் , தெற்கு சீனா , ஹைனன் மாகாணம் ,

Similar results prove feasibility of adenovirus vector COVID-19 vaccines


CHINA / SOCIETY
By
In-Depth reporter covering COVID-19 vaccines and health, Tibetan issue, China-ASEAN relations, among others.
Hu Yuwei and Leng Shumei Published: Feb 28, 2021 10:10 PM Updated: Feb 28, 2021 10:30 PM
CanSinoBIO s vaccine Photo: VCG
 The virus vector used in the vaccine produced by Chinese company CanSinoBIO is safer for the human body and easier to produce, the company CEO said Sunday after China and the US both approved their single-shot recombinant adenovirus vector COVID-19 vaccines last week, which, experts say, proves the feasibility of the method used to develop COVID-19 vaccines and should see faster vaccinations.
The US Food and Drug Administration (FDA) authorized Johnson & Johnson s recombinant adenovirus vector COVID-19 vaccine on Saturday, making it the first single dose COVID-19 vaccine available in the US, CNN reported, noting that data showed the vaccine is safe and effective. ....

United States , Mexico City , Distrito Federal , South Africa , Zhuang Shilihe , Yu Xuefeng , Cansino Biologics , Mexico Foreign Affairs Ministry , Drug Administration , Mexico City International Airport , China National Medical Products Administration On , National Medical Products Administration , Novel Coronavirus Vaccine , Adenovirus Type , Global Times , Central America , South America , Foreign Affairs Ministry , Covid 19 , ஒன்றுபட்டது மாநிலங்களில் , மெக்ஸிகோ நகரம் , திஸ்திரிதோ கூட்டாட்சியின் , கேன்சினோ உயிரியல் , மெக்ஸிகோ வெளிநாட்டு வாழ்க்கைத்தொழில்கள் அமைச்சகம் , மெக்ஸிகோ நகரம் சர்வதேச விமான , உலகளாவிய முறை ,